Title:
モリンダ・シトリフォリアベースの5-LOXおよび15-LOXの製剤
Document Type and Number:
Japanese Patent JP2008501793
Kind Code:
A
Abstract:
The present invention is directed to methods and formulations for inhibiting Lipoxygenase enzymes that function to biosynthesize or metabolize arachidonic acid into its intermediate Leukotriene constituents, as well as a method and formulation for treating and preventing diseases, including inflammatory diseases, and the symptoms associated with such diseases. The present invention methods and formulations effectively function as such through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration, wherein the processed Morinda citrifolia product may comprise one or more isolated active ingredients.
Inventors:
Pal, Afa, Keherty
Jou, Bin-Nan
Sue, Chen
Jensen, Claude, Jarakae
Story, steven
Jou, Bin-Nan
Sue, Chen
Jensen, Claude, Jarakae
Story, steven
Application Number:
JP2007527168A
Publication Date:
January 24, 2008
Filing Date:
June 18, 2004
Export Citation:
Assignee:
Tahitian Noni International Inc.
International Classes:
A61K36/18; A23L1/30; A23L2/02; A61K36/00; A61K36/746; A61P1/02; A61P1/14; A61P3/10; A61P9/12; A61P11/06; A61P17/02; A61P19/02; A61P19/08; A61P25/00; A61P25/06; A61P29/00; A61P31/00; A61P35/00; A61P37/04; A61P37/08; A61P39/06; A61P43/00
Attorney, Agent or Firm:
Reiko Tanaka
Hitoshi Nakamura
Hitoshi Nakamura